Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene

Belani CP (2002) Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer 3(Suppl 1):S5–S9

Arriagada R, Bergman B, Dunant A et al (2004) International adjuvant lung cancer trial collaborative group. N Engl J Med 350:351–360

Kunz M, Ibrahim SM (2003) Molecular responses to hypoxia in tumor cells. Mol Cancer 2(1):23

Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47

Fedele AO, Whitelaw ML, Peet DJ (2002) Regulation of gene expression by the hypoxia-inducible factors. Mol Interv 2(4):229–243

Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. PNAS 92:5510–5514

Manfred Kunz, Saleh M Ibahim (2003) Molecular responses to hypoxia in tumor cells. Mol Cancer 2:23

Claudio J Conti (2002) Vascular endothelial growth factor: regulation I the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. Oncologist 7(suppl 3):4–11

Semenza G (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14(16):1983–1991

Goda N, Ryan HE, Khadivi B et al (2003) Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 23(1):359–369

Postovit LM, Adams MA, Lash GE et al (2002) Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem 277:35730

Balaji K, Shannon B-D, Brain K et al (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor. Cancer Res 63:1138–1143

Frederiksen LJ, Siemens DR, Heaton JP et al (2003) Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate. J Urol 170(3):1003–1007

Teicher BA (1994) Hypoxia and drug resistance. Cancer Metastasis Rev 13:139

Wartenberg M, Ling FC, Muschen M et al (2003) Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 17(3):503–505

Comerford KM, Wallace TJ, Karhausen J et al (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62(12):3387–3394

Kizaka-Kondoh S, Inoue M, Harada H, Hiraoka M (2003) Tumor hypoxia: a target for selective cancer therapy. Cancer Sci 94(12):1021–1028

Chen J, Zhao SJ, Nakada K et al (2003) Dominant-negative hypoxia-inducible factor-1α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 162(4):1283–1291

Kung AL, Wang S, Klco JM et al (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6:1335–1340

Stoeltzing O, McCarty MF, Wey JS et al (2004) Role of hypoxia-inducible factor-1in gastric cancer cell growth, angiogenesis and vessel maturation. JNCI 96:946–956

Unruh A, Ressel A, Mohamed HG et al (2003) The hypoxia-inducible factor-1↑ is a negative factor for tumor therapy. Oncogene 22:3213–3220

Erler JT, Cawthorne CJ, Williams KJ et al (2004) Hypoxia-mediated down-regulation of Bid and Bax in tumours occurs via HIF-1-dependent and-independent mechanisms and contributes to drug resistance. Mol Cell Biol 24:2875–2889

Yeo EJ, Chun YS, Cho YS et al (2003) YC-1 a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 95:516–525

Michaela S, Michael AM, Matthial E (2003) Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 10:245–256

Tuschl T, Borkhardt A (2002) Small interfering RNAs. Mol Interv 2:158–167

Zhang M, Zhang Xin, Bai CX et al (2005) Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer. Genet Vaccines Ther 3:5–16

Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW (2004) Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36(1):1–12

Bruick RK (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. PNAS 97(16):9082–9087

Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, Dayan F, Ginouves A, Berra E, Pouyssegur J (2004) HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 68(6):971–980

Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1_, HIF-2-Expression in Lung Epithelial Cells (2004) J Biol Chem 279(15):14871–14878

Maxwell P, Wiesener M, Chang G-W et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275

Kamura T, Sato S, Iwai K et al (2000) Activation of HIF1 alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. PNAS 97(19):10430–10435

Ivan M, Kondo K, Yang H et al (2001) HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292(5516):464–468

Jaideep VT, Gerard P Zambetti, Kazuhiko Arimori, Erin G Schuetz, John D (1997) Schuetz: p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. PNAS 94:11037–11042